CAILIN TRAVIS: Open Payments
NPI 1881341238 · FAIRMOUNT CITY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$440 in 24 payments from 8 companies in 2025. Trend: 2023 $310 · 2024 $185 · 2025 $440
Food & beverage: $440
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $147 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $76 |
| Lilly USA, LLC | 4 | $72 |
| Sumitomo Pharma America, Inc. | 3 | $47 |
| Exact Sciences Corporation | 2 | $37 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
| Dexcom, Inc. | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: Ozempic, CAPLYTA, MOUNJARO, GEMTESA, Cologuard Collection Kit, Kerendia, Wegovy, Dexcom G6 Transmitter.
Industry payments across PA — which companies pay providers there.
